Edesa Biotech is trading at $3.33, down 5.13%, with no specific catalyst identified for the October 12 decline.

  • The company’s news page shows no October 12 release.
  • The broader market was nearly flat, with mixed index moves; available evidence does not establish a market-wide explanation.
  • Shares also closed lower on October 9 and October 8, continuing the recent weak trend, but those moves do not establish the cause of the current decline.